Alan H. Baik

850 total citations
20 papers, 507 citations indexed

About

Alan H. Baik is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Alan H. Baik has authored 20 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Alan H. Baik's work include Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Mitochondrial Function and Pathology (3 papers). Alan H. Baik is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Mitochondrial Function and Pathology (3 papers). Alan H. Baik collaborates with scholars based in United States, France and Australia. Alan H. Baik's co-authors include Isha H. Jain, Javid J. Moslehi, Katy K. Tsai, Joe‐Elie Salem, Mandar A. Aras, Douglas B. Johnson, Nina Shah, Olalekan O. Oluwole, Aarti Asnani and Amy J. Wagers and has published in prestigious journals such as Cell, Circulation and Molecular Cell.

In The Last Decade

Alan H. Baik

16 papers receiving 494 citations

Peers

Countries citing papers authored by Alan H. Baik

Since Specialization

Citations

This map shows the geographic impact of Alan H. Baik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan H. Baik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan H. Baik more than expected).

Fields of papers citing papers by Alan H. Baik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan H. Baik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan H. Baik. The network helps show where Alan H. Baik may publish in the future.

Co-authorship network of co-authors of Alan H. Baik

This figure shows the co-authorship network connecting the top 25 collaborators of Alan H. Baik. A scholar is included among the top collaborators of Alan H. Baik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan H. Baik. Alan H. Baik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Statin Use in Patients With Cancer 2025 ·JACC Advances ·(unknown), (unknown), (unknown), Alan H. Baik, Brian Schulte	0
2	Acute radiation-induced pericarditis complicated by polymicrobial infectious pericarditis in a patient with mediastinal sarcoma: a case report 2024 ·European Heart Journal - Case Reports ·(unknown), Yoo Jin Lee, Alan H. Baik	0
3	Left atrial strain is reduced following trastuzumab in breast cancer patients 2024 ·Echocardiography ·Mats Christian Højbjerg Lassen, (unknown), Tor Biering‐Sørensen, (unknown), Michelle Melisko, (unknown), Alan H. Baik, Mandar A. Aras, Atif Qasim	1
4	Cancer Therapy and Exercise Intolerance: The Heart Is But a Part 2024 ·JACC CardioOncology ·(unknown), Stephen Foulkes, Alan H. Baik, Jessica M. Scott, Rhian M. Touyz, Joerg Herrmann, Mark J. Haykowsky, André La Gerche, Erin J. Howden	8
5	Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report 2023 ·Cardio-Oncology ·(unknown), (unknown), (unknown), Krishan Soni, Yoo Jin Lee, Claire K. Mulvey, Alan H. Baik	5
6	In vivo protein turnover rates in varying oxygen tensions nominate MYBBP1A as a mediator of the hyperoxia response 2023 ·Science Advances ·Xuewen Chen, (unknown), Alan H. Baik, Andrea Fossati, Erica Stevenson, (unknown), (unknown), Tien Peng, Michael A. Matthay, Michela Traglia, Alexander R. Pico, Daniel F. Jarosz, Abigail Buchwalter, Sina Ghaemmaghami, Danielle L. Swaney, Isha H. Jain	1
7	Oxygen toxicity causes cyclic damage by destabilizing specific Fe-S cluster-containing protein complexes 2023 ·Molecular Cell ·Alan H. Baik, (unknown), Xuewen Chen, Bruno B. Queliconi, (unknown), Ankur Garg, Mazharul Maishan, Alexandre Rosa Campos, Michael A. Matthay, Isha H. Jain	31
8	Equity in Cardio-Oncology Care and Research: A Scientific Statement From the American Heart Association 2023 ·Circulation ·Daniel Addison, (unknown), Alan H. Baik, Michael G. Fradley, Tochi M. Okwuosa, Kerryn W. Reding, Kathleen E. Simpson, Giselle Alexandra Suero‐Abreu, En‐Hua Yang, Clyde W. Yancy	35
9	POLYMICROBIAL INFECTIOUS PERICARDITIS COMPLICATED BY CARDIAC TAMPONADE IN A PATIENT WITH MEDIASTINAL SARCOMA 2023 ·Journal of the American College of Cardiology ·(unknown), Alan H. Baik	0
10	CATECHOLAMINE INDUCED CARDIOMYOPATHY COMPLICATED BY LV THROMBUS AND STROKE - COMPLEX MANAGEMENT OF PHEOCHROMOCYTOMA 2023 ·Journal of the American College of Cardiology ·(unknown), Connor O’Brien, Alan H. Baik	0
11	Hypoxia signaling and oxygen metabolism in cardio-oncology 2022 ·Journal of Molecular and Cellular Cardiology ·Alan H. Baik	10
12	Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis 2021 ·JAMA Cardiology ·Lorenz Lehmann, Jennifer Cautela, Nicolas L. Palaskas, Alan H. Baik, Wouter C. Meijers, Yves Allenbach, Joachim Alexandre, Tienush Rassaf, Oliver J. Müller, Mandar A. Aras, Aarti Asnani, Anita Deswal, Michal Laufer‐Perl, Franck Thuny, Mathieu Kernéis, Salim S. Hayek, Stéphane Éderhy, Joe‐Elie Salem, Javid J. Moslehi	95
13	Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association 2021 ·Circulation Research ·Aarti Asnani, Javid J. Moslehi, Bishow B. Adhikari, Alan H. Baik, Andreas Beyer, Rudolf A. de Boer, Alessandra Ghigo, Isabella M. Grumbach, Salvia Jain, Han Zhu	47
14	Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors 2021 ·Clinical Science ·Alan H. Baik, Katy K. Tsai, David Y. Oh, Mandar A. Aras	24
15	Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies 2021 ·Circulation Research ·Alan H. Baik, Olalekan O. Oluwole, Douglas B. Johnson, Nina Shah, Joe‐Elie Salem, Katy K. Tsai, Javid J. Moslehi	80
16	Turning the Oxygen Dial: Balancing the Highs and Lows 2020 ·Trends in Cell Biology ·Alan H. Baik, Isha H. Jain	52
17	EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection 2016 ·DSpace@MIT (Massachusetts Institute of Technology) ·Benjamin A. Olenchock, Javid J. Moslehi, Alan H. Baik, (unknown), William J. Gibson, Abhishek A. Chakraborty, Kerry A. Pierce, Christine Miller, Eric A. Hanse, Ameeta Kelekar, Amy J. Wagers, Clary B. Clish, William G. Kaelin, Shawn M. Davidson, (unknown), Matthew G. Vander Heiden	1
18	EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection 2016 ·Cell ·Benjamin A. Olenchock, Javid J. Moslehi, Alan H. Baik, Shawn M. Davidson, (unknown), William J. Gibson, Abhishek A. Chakraborty, Kerry A. Pierce, Christine Miller, Eric A. Hanse, Ameeta Kelekar, Lucas B. Sullivan, Amy J. Wagers, Clary B. Clish, Matthew G. Vander Heiden, William G. Kaelin	107
19	ACUTE HYPOXIA-INDUCIBLE FACTOR EGLN1 INACTIVATION PROTECTS AGAINST ISCHEMIA-REPERFUSION INJURY BY REGULATION OF GLUCOSE OXIDATION AND REACTIVE OXYGEN SPECIES GENERATION 2013 ·Journal of the American College of Cardiology ·Alan H. Baik, (unknown), Javid J. Moslehi, William G. Kaelin	2
20	Genetic Subdivision of Chemosynthetic Endosymbionts of Solemya velum along the Southern New England Coast 2009 ·Applied and Environmental Microbiology ·Frank J. Stewart, Alan H. Baik, Colleen M. Cavanaugh	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact